As Per the Report, the Size of the Asia Pacific Coagulation/Hemostasis Analyzer Market is valued at USD 710 million in 2019 and projected to grow at a CAGR of 10.55%, to reach USD 1180 million by 2024 during the forecast period 2019-2024.
Coagulation testing procedures describe a set of methods used for the checking hemostasis systems. Hemostasis is the process in which bleeding is stopped from a blood vessel. Coagulometer is the instrument that is used in the medical laboratories to analyze coagulation systems. Many of the methods which are used in laboratories today were developed more than fifty years ago.
All the methods for analyzing coagulation systems can broadly be divided into two types, global tests, and local tests. Global tests produce results for the whole clotting cascade. Examples of global tests include the Thrombodynamics test, Thromboelastography, and Thrombin generation test. They play an important role in the initial phase of diagnostics by producing a detailed analysis of the coagulation cascade. Local tests generate the results of different components of the blood coagulation cascade. Examples of local testing include the Prothrombin time test and Partial Thromboplastin time.
The Asia-Pacific Coagulation/Hemostasis Analyzer market is driven by rising geriatric demographics, an increasing number of people suffering from chronic blood disorders, rising incidence of chronic diseases, poor lifestyle choices and an increase of foreign investments among others. The huge expansion of hospitals and healthcare centers is also propelling the growth of this market in developing nations of Asia-Pacific.
Asia Pacific Coagulation/Hemostasis Analyzer Market has been segmented and sub-segmented into the following categories
On the basis of test, prothrombin time testing has the largest market share in this segment and is also the fastest-growing due to increasing automation of this process in laboratories.
On the basis of product, Clinical laboratory analyzers have the largest market in this segment.
On the basis of end-user, Clinical laboratories have the largest share in the segment.
On the basis of technology, the Optical segment has the largest market share and is also the fastest-growing in this segment.
On the basis of region, the Asia-Pacific market is the fastest-growing in the world and has the third-largest share after the Europe region. Factors such as a huge patient base, rising foreign investments, and poor lifestyle choices are expected to propel the market growth in the region.
Top Companies dominating the Asia Pacific Coagulation/Hemostasis Analyzer Market Profiled in the Report are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), International Technidyne Corporation (U.S.), Nihon Kohden Corporation (Japan) and Diagnostica Stago (France).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Test
5.1.1 ACT
5.1.2 aPTT
5.1.3 D Dimer testing
5.1.4 Platelet Function Test
5.1.5 Prothrombin Time Testing
5.1.6 Anti-Factor Xa Test
5.1.7 Heparin and Protamine Dose Response Test for ACT
5.1.8 Fibrinogen Testing
5.1.9 Other Coagulation Tests
5.1.10 Y-o-Y Growth Analysis, By Test
5.1.11 Market Attractiveness Analysis, By Test
5.1.12 Market Share Analysis, By Test
5.2 Product
5.2.1 PoC Testing Analyzers
5.2.2 Clinical Laboratory Analyzers
5.2.2.1 Systems
5.2.2.1.1 Manual Systems
5.2.2.1.2 Automated Systems
5.2.2.1.3 Semiautomated Systems
5.2.2.2 Consumables
5.2.2.2.1 Reagents
5.2.2.2.2 Standards, Calibrations and Controls
5.2.3 Y-o-Y Growth Analysis, By Product
5.2.4 Market Attractiveness Analysis, By Product
5.2.5 Market Share Analysis, By Product
5.3 End Users
5.3.1 Clinical Laboratories
5.3.2 Point-Of-Care Testing
5.3.3 Other End Users
5.3.4 Y-o-Y Growth Analysis, By End Users
5.3.5 Market Attractiveness Analysis, By End Users
5.3.6 Market Share Analysis, By End Users
5.4 Technology
5.4.1 Electrochemical Technology
5.4.2 Optical Technology
5.4.3 Mechanical Technology
5.4.4 Other Technologies
5.4.5 Y-o-Y Growth Analysis, By Technology
5.4.6 Market Attractiveness Analysis, By Technology
5.4.7 Market Share Analysis, By Technology
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Test
6.1.3.2 By Product
6.1.3.3 By End Users
6.1.3.4 By Technology
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Test
6.1.4.2 By Product
6.1.4.3 By End Users
6.1.4.4 By Technology
6.1.5 Market Share Analysis
6.1.5.1 By Test
6.1.5.2 By Product
6.1.5.3 By End Users
6.1.5.4 By Technology
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Siemens AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific Inc.
8.3 Roche Diagnostics
8.4 Alere Inc.
8.5 Sysmex Corporation
8.6 Helena Laboratories
8.7 Instrumentation Laboratory
8.8 International Technidyne Corporation
8.9 Nihon Kohden Corporation
8.10 Diagnostica Stago
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
